SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2018

At March 31, 2018 and December 31, 2017, intangible assets were measured at fair value on a nonrecurring basis as shown in the following tables.

	Quoted Price in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Balance at March 31, 2018		Impairment Loss
Patents and other technologies	$	—	$	—	$	1,501,367	$	1,501,367	$	—

	Quoted Price in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Balance at December 31, 2017		Impairment Loss
Patents and other technologies	$	—	$	—	$	1,583,260	$	1,583,260	$	923,769
Goodwill		—		—		—		—		397,569
Total	$	—	$	—	$	1,583,260	$	1,583,260	$	1,321,338

At March 31, 2018 and December 31, 2017, the Company’s cash balances by geographic area were as follows:

The following table presents a reconciliation of basic and diluted net loss per share:

	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
Net loss available to Avalon GloboCare Corp. for basic and diluted net loss per share of common stock	$	(1,481,579	)	$	(549,333	)
Weighted average common stock outstanding - basic and diluted		69,781,733			62,595,289
Net loss per common share attributable to Avalon GloboCare Corp. - basic and diluted	$	(0.02	)	$	(0.01	)